Souvenaid in Singapore:
Could this drink help dementia?
Souvenaid is a medical food product that was designed to support brain function, particularly in individuals with mild Alzheimer’s disease. This article will provide an in-depth review of Souvenaid in Singapore, its price, availability, and ingredients, and whether there are any benefits to taking it.
This article is provided for informational purposes only, and does not represent an endorsement of any product or treatment by iKare.
Souvenaid in Singapore: A Review
Souvenaid is a medical food product developed by Nutricia, a healthcare nutrition company. The product is formulated to purportedly support brain function, particularly in individuals with mild Alzheimer’s disease.
The key ingredients in Souvenaid include a unique blend of omega-3 fatty acids, phospholipids, antioxidants, and B-vitamins. These ingredients have been scientifically proven to support brain function, including memory and attention. Additionally, the formula is designed to support the formation and maintenance of neural connections, which is essential for optimal brain function.
Souvenaid is a convenient and easy-to-use product. It comes in a ready-to-drink bottle, making it easy to consume on the go. The product is also available in different flavors, such as vanilla and chocolate, to make it more appealing to individuals who may have a sensitivity to certain tastes or textures.
In clinical studies, Souvenaid has been shown to have a positive impact on brain function in individuals with mild Alzheimer’s disease. Participants who consumed Souvenaid on a daily basis showed improvements in memory and attention, compared to those who did not consume the product.
Where is Souvenaid in Singapore made from?
Souvenaid is made by Nutricia Advanced Medical Nutrition, a subsidiary in the healthcare field of Danone, a large French food corporation. The Souvenaid drinks are manufactured in the Netherlands.
Souvenaid in Singapore: Price
The price of Souvenaid in Singapore may vary depending on the retailer and location. On average, a bottle of Souvenaid costs around $5. The dosage is meant to be one bottle per day, which means the monthly cost will be around $150 SGD. While this may seem like a significant investment, you may consider the potential benefits of the product.
Souvenaid in Singapore: Where to Buy
Souvenaid is available at a variety of retailers, including online and brick-and-mortar stores in Singapore. Some of the most popular retailers that carry Souvenaid include Watsons, Guardian, Unity, hospital pharmacies, and Amazon.
Additionally, Souvenaid can also be purchased directly from the Nutricia website, as well as Lazada and Qoo10. This is a convenient option for individuals who are unable to find the product at a nearby retailer or who prefer to purchase the product online.
Evidence for Souvenaid
A number of clinical trials have been conducted to assess the effectiveness of Souvenaid in improving brain function and memory in people with Alzheimer’s.
Nutricia has conducted three clinical trials on Souvenaid to date. The Souvenir I study involved 225 individuals who had mild Alzheimer’s disease with Mini-Mental State Examination scores of 20-26. Half of them received Souvenaid for 12 weeks, and the other half took a placebo. Although there was no change in the Alzheimer’s Disease Assessment Scale-cognitive subscale (ADAS-cog), which is widely used to assess Alzheimer’s treatments, Souvenaid improved delayed verbal recall test scores.
The S-Connect study included 527 participants with mild-to-moderate Alzheimer’s disease with MMSE scores of 14-24. All participants were taking Alzheimer’s medication, and half of them received Souvenaid for 24 weeks, while the other half took a placebo. The ADAS-Cog score changes did not differ between the two groups, and Souvenaid was well-tolerated in combination with standard Alzheimer’s medication.
The Souvenir II study included 259 people with mild Alzheimer’s disease with MMSE scores of 20 or more. Half of them received Souvenaid for 24 weeks, and the other half took a placebo. Souvenaid modestly enhanced the memory score of the Neuropsychological Test Battery.
A European Union-funded study in 311 people with prodromal Alzheimer’s disease demonstrated a slight improvement in some memory measures and the Clinical Dementia Rating scale in individuals who took Souvenaid compared to those who took a placebo. Three-year data (not yet published) showed that Souvenaid improved five measures from the Neuropsychological Test Battery in people who took it, while there was less loss of hippocampal volume, indicating a biological mechanism for the cognitive and overall function improvement.
Currently, there is inadequate evidence to support the routine use of Souvenaid for people with moderate to advanced Alzheimer’s disease.
In conclusion, the evidence suggests that Souvenaid may be an option to help improve brain function and memory in people with mild Alzheimer’s disease. While more research is needed, the results of clinical trials to date are encouraging.
Note that so far, Nutrica has conducted clinical trials on Souvenaid solely presenting results based on standard cognitive assessments. No research has been conducted to examine the impact of Souvenaid on daily memory ability, daily activities, mood, behavior, or overall quality of life. Therefore, it is uncertain whether individuals or their loved ones will observe any difference in taking Souvenaid. Alzheimer’s disease is a degenerative illness, and we can anticipate a gradual decline in brain function, including memory abilities.
Souvenaid in Singapore: Ingredients
The ingredients in Souvenaid include the patented Fortasyn™Connect, selected to support brain function, particularly in individuals with mild Alzheimer’s disease. The key ingredients, with include:
Omega-3 fatty acids: Omega-3 fatty acids are essential for brain function and have been shown to improve memory and attention.
Phospholipids: Phospholipids play a key role in the formation and maintenance of neural connections, which is essential for optimal brain function.
Antioxidants: Antioxidants like vitamin C and E help to protect the brain against damage from free radicals and oxidative stress.
B-vitamins: B-vitamins play a crucial role in brain function, including memory and attention.
Choline: a nutrient essential to brain health.
- Nucleotides: uridine monophosphate (UMP)
It also includes calories and proteins like a regular oral nutritional supplement.
While it cannot cure dementia, Souvenaid may help to support brain function, as well as provide nutrients to help prevent frailty. However, a Cochrane systematic review says that there is conflicting evidence on combined cognitive-functional outcomes in prodromal Alzheimer’s disease and mild Alzheimer’s dementia, so further research is required before we know definitively whether Souvenaid is good for people with dementia.
If you’re interested in learning more about Souvenaid or other nutrition concerns, be sure to speak with a healthcare professional or the iKare dietitian.
For more information, you can call:
- HPB Dementia Infoline: 1800 223 1123. For general inquiries on dementia
- Institute of Mental Health (IMH): 6389 2000. For general inquiries on clinical services and psychiatric care.
- Samaritans of Singapore (SOS): 1800 221 4444. Emotional support for anyone in.
- Dementia Singapore: 6377 0700. For caregiver support and dementia care services.
- Singapore Association of Mental Health (SAMH): 1800 283 7019. For general inquiries on rehabilitative and outreach services
We are here for you. Contact Us Today. Do not hesitate and contact us for any information. Our friendly team is always available to see how iKare can help you.
Scheltens P, et al. Efficacy of Souvenaid in mild Alzheimer’s disease – results from a randomised, controlled trial. J Alzheimers Dis. 2012;31:225-236.
Scheltens P, et al. Efficacy of a medical food in mild Alzheimer’s disease: a randomized controlled trial. Alzheimer’s & Dementia. 2010;6:1-10.
Shah R, et al. The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer’s disease. Alzheimer’s Research & Therapy. 2013;5:59.